The finding that genes encoding enzymes that modify histone proteins are among the targets of certain mutant forms of the p53 protein sheds light on how these mutations cause cancer beyond p53 inactivation. See Article p.206
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
npj Breast Cancer Open Access 19 January 2017
-
Genetic differences among ethnic groups
BMC Genomics Open Access 21 December 2015
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
References
Vogelstein, B. & Kinzler, K. W. Cell 70, 523–526 (1992).
Muller, P. A. J. & Vousden, K. H. Nature Cell Biol. 15, 2–8 (2013).
Zhu, J. et al. Nature 525, 206–211 (2015).
Freed-Pastor, W. A. & Prives, C. Genes Dev. 26, 1268–1286 (2012).
Garcia, P. B. & Attardi, L. D. Semin. Cell Dev. Biol. 27, 74–85 (2014).
Alexandrova, E. M. et al. Nature 523, 352–356 (2015).
Do, P. M. et al. Genes Dev. 26, 830–845 (2012).
Zhang, P., Bergamin, E. & Couture, J.-F. Biopolymers 99, 136–145 (2013).
Shilatifard, A. Annu. Rev. Biochem. 81, 65–95 (2012).
Pfister, N. T. et al. Genes Dev. 29, 1298–1315 (2015).
Joerger, A. C., Ang, H. C. & Fersht, A. R. Proc. Natl Acad. Sci. USA 103, 15056–15061 (2006) .
Ford, D. J. & Dingwall, A. K. Cancer Genet. 208, 178–191 (2015).
Freed-Pastor, W. A. et al. Cell 148, 244–258 (2012).
Weissmueller, S. et al. Cell 157, 382–394 (2014).
Author information
Authors and Affiliations
Corresponding authors
Related links
Rights and permissions
About this article
Cite this article
Prives, C., Lowe, S. Mutant p53 and chromatin regulation. Nature 525, 199–200 (2015). https://doi.org/10.1038/nature15212
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature15212
This article is cited by
-
Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii
International Journal of Clinical Oncology (2023)
-
Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
npj Breast Cancer (2017)
-
Molecularly targeted therapies for p53-mutant cancers
Cellular and Molecular Life Sciences (2017)
-
Genetic differences among ethnic groups
BMC Genomics (2015)